News|Articles|February 27, 2024

Philips Set to Launch Enhanced Neurovascular Imaging System at ECR

Author(s)Jeff Hall

Emphasizing upgraded angio suite capabilities as well as improved 2D and 3D imaging, Philips will unveil the Azurion Neuro Biplane System at the European Congress of Radiology.

In order to help enhance interventional workflows for neurovascular procedures, Philips is slated to debut the Azurion Neuro Biplane System at the European Congress of Radiology (ECR).

The Azurion Neuro Biplane System offers an integrated combination of 2D and 3D imaging with low-dose imaging capabilities to enhance stroke assessment and timely precision intervention in neurovascular procedures, according to Philips.

“Working closely with leading interventionists, we designed the latest Azurion neuro biplane (system) to meet their requirements of superior patient care, optimized angio suite performance, and efficient return on investment,” said Mark Stoffels, the business leader of image guided therapy systems at Philips. “Together, I am confident we can continue to reduce the impact of stroke, helping more patients to recover faster and reducing long-term impact on their health.”

The company noted that other key features with the Azurion Neuro Biplane System include automated beam rotation, improved C-arm rotation and X-ray detector positioning flexibility.


Related to this article

What CCTA-Based AI Detection of Coronary Inflammation May Reveal About Patients with No Traditional CV Risk Factors
Elevated coronary inflammation, measured with the CCTA-derived and AI-enabled perivascular fat attenuation index (FAI) score, was associated with over a 12-fold higher risk for cardiovascular mortality in patients with no diabetes, hypertension, smoking history or obesity, according to new research presented at the European Society of Cardiology (ESC) Congress.